Revive Therapeutics Ltd
Change company Symbol lookup
Select an option...
RVVTF Revive Therapeutics Ltd
GFF Griffon Corp
PSXP Phillips 66 Partners LP
EQ Equillium Inc
TSLA Tesla Inc
OPK OPKO Health Inc
PNW Pinnacle West Capital Corp
ROLL RBC Bearings Inc
GLAD Gladstone Capital Corp
PAC Grupo Aeroportuario del Pacifico SAB de CV
Go

Health Care : Pharmaceuticals | Small Cap Blend
Based in Canada
Company profile

Revive Therapeutics Ltd (Revive) is engaged in commercializing treatments for rare diseases, such as Cystinuria, Wilson's disease and Rett syndrome. The Company has completed a Phase II-A study for acute gout flares in the United States. The Company's business model focuses on finding new uses of old drugs with the objective of finding a partner or partners to bring the new use drug to the marketplace. The Company is focused on the development of Bucillamine for the treatment of cystinuria (REV-004). The Company's product pipeline includes Bucillamine for the treatment of acute gout flares (REV-002), Tianeptine for treatment of Rett Syndrome (REV-003), and Bucillamine for treatment of Wilson's disease (REV-005). The Company is focused on the development and commercialization of drugs for underserved medical needs. The Company is also evaluating additional drug repurposing candidates and formulations.

Closing Price
$0.1456
Day's Change
0.0026 (1.82%)
Bid
--
Ask
--
B/A Size
--
Day's High
0.1512
Day's Low
0.128
Volume
(Above Average)
Volume:
2,307,591

10-day average volume:
2,039,400
2,307,591
  • Prev Close
    0.143
  • Today's Open
    0.128
  • Day's Range
    0.128-0.1512
  • Avg Vol (10-day)
    2.0M
  • Last (time)
    3:59p ET 10/30/20
  • Last (size)
    2.5K
  • 52-Wk Range
    0.0173 - 0.50
    LowHigh
  • (12/16/19 - 07/01/20)
    741.62%
  • 226.0%
  • Market Cap
    23.9M
  • Shares Outstanding
    163.9M
  • -0.03
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • -0.6
  • 0.05
  • --

Latest News

October 26, 2020
9:21 am ET
Globe Newswire
October 20, 2020
8:00 am ET
Accesswire
7:22 am ET
Globe Newswire
September 29, 2020
8:38 am ET
Globe Newswire
September 24, 2020
9:45 am ET
PR Newswire
September 21, 2020
9:21 am ET
Globe Newswire
September 16, 2020
8:00 am ET
Globe Newswire
September 15, 2020
8:50 am ET
PR Newswire
September 02, 2020
8:31 am ET
Globe Newswire
August 14, 2020
8:44 am ET
Globe Newswire
August 11, 2020
8:40 am ET
Globe Newswire
August 05, 2020
9:00 am ET
Globe Newswire
Go to all current & historical news

Events

There are no calendar events for RVVTF.

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.